ChemicalBook >> CAS DataBase List >>ASC-J9

ASC-J9

CAS No.
52328-98-0
Chemical Name:
ASC-J9
Synonyms
GO-Y 025;Indiscriminate;Dimethylcurcumin;Dimethylcurcumin, ≥95%;4',4"-O,O-DIMETHYLCURCUMIN-D6;1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one;(1E,4Z,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one;1,4,6-Heptatrien-3-one, 1,7-bis(3,4-diMethoxyphenyl)-5-hydroxy-,(1E,4Z,6E)-;(1E,4Z,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one (ASC-J9);Dimethylcurcumin【(1E,4Z,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one】
CBNumber:
CB52624078
Molecular Formula:
C23H24O6
Molecular Weight:
396.43
MDL Number:
MOL File:
52328-98-0.mol
Last updated:2023-09-20 16:43:00

ASC-J9 Properties

Melting point 129-130℃
Boiling point 588.6±50.0 °C(Predicted)
Density 1.191
storage temp. Store at -20°C
solubility insoluble in EtOH; insoluble in H2O; ≥16.65 mg/mL in DMSO
form solid
pka 8.34±0.60(Predicted)
FDA UNII D60XLY608D

SAFETY

Risk and Safety Statements

ASC-J9 price More Price(28)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML3413 ASC-J9 ≥98% (HPLC) 52328-98-0 5MG $64.8 2024-03-01 Buy
Sigma-Aldrich SML3413 ASC-J9 ≥98% (HPLC) 52328-98-0 25MG $261 2024-03-01 Buy
Cayman Chemical 10008187 Dimethylcurcumin ≥95% 52328-98-0 1mg $44 2024-03-01 Buy
Cayman Chemical 10008187 Dimethylcurcumin ≥95% 52328-98-0 5mg $193 2024-03-01 Buy
Cayman Chemical 10008187 Dimethylcurcumin ≥95% 52328-98-0 10mg $341 2024-03-01 Buy
Product number Packaging Price Buy
SML3413 5MG $64.8 Buy
SML3413 25MG $261 Buy
10008187 1mg $44 Buy
10008187 5mg $193 Buy
10008187 10mg $341 Buy

ASC-J9 Chemical Properties,Uses,Production

Uses

Dimethylcurcumin selectively enhances the degradation of androgen receptor. Dimethylcurcumin is a related compound of Curcumin (C838500).

Biological Activity

asc-j9, is antitumor agent. asc-j9 suppresses castration-resistant prostate cancer growth via degradation of full-length and splice variant androgen receptors targeting both far- and ar3-mediated pca growth by asc-j9 may represent the novel therapeutic approach to suppress castration-resistant pca. asc-j9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor.the androgen receptor (ar) is a type of nuclear receptor that is activated by binding either of the androgenic hormones, testosterone, or dihydrotestosterone in the cytoplasm and then translocating into the nucleus. [1]the binding of an androgen to the androgen receptor(ar) results into a conformational change, in turn, which causes dissociation of hsp, transport from the cytosol into the cell nucleus, and dimerization. the ar dimer binds to a specific sequence of dna known as hre which can interact with other proteins in the nucleus, leading to up-regulation or down-regulation of specific gene transcription.[2]asc-j9, the ar degradation enhancer, suppressed both macrophage migration and subsequent pca cell invasion. additionally, asc-j9 can regulate pstat3-ccl2 signaling using two pathways: an ar-dependent pathway via inhibiting pias3 expression and an ar-independent pathway via direct inhibition of the stat3 phosphorylation/activation through mouse model in vivo with orthotopically injected tramp-c1 cells. in conclusion,a new and better therapeutic strategies using asc-j9 alone or a combinational therapy that simultaneously targets androgens/ar signaling and pias3-pstat3-ccl2 signaling to better battle pca growth and metastasis at castration-resistant stage.[3]1. lu nz. et al. "international union of pharmacology. lxv. the pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors". pharmacol. rev. 2006, 58 (4): 782–97.2. heemers hv, tindall dj. "androgen receptor (ar) coregulators: a diversity of functions converging on and regulating the ar transcriptional complex". endocr. rev. 2007, 28 (7): 778–808.3. lin th. et al. “anti-androgen receptor asc-j9 versus anti-androgens mdv3100 (enzalutamide) or casodex (bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and stat3-ccl2 signaling.” cell deathdis. 2013,4:e764

ASC-J9 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 127)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32715 60
Shanghai Zheyan Biotech Co., Ltd.
18017610038 zheyansh@163.com CHINA 3620 58
career henan chemical co
+86-0371-86658258 sales@coreychem.com China 29914 58
Chengdu GLP biotechnology Co Ltd
028-87075086 13350802083 scglp@glp-china.com CHINA 1824 58
Chengdu Biopurify Phytochemicals Ltd.
+8618080483897 sales@biopurify.com China 3424 58
Shaanxi Pioneer Biotech Co., Ltd .
+8613259417953 sales@pioneerbiotech.com China 3000 58
Chongqing Chemdad Co., Ltd
+86-023-6139-8061 +86-86-13650506873 sales@chemdad.com China 39916 58
Univar Solutions(China) Co., Ltd.
+8615902132654 ivy.zhuang@univarsolutions.com China 654 58
Neostar United (Changzhou) Industrial Co., Ltd.
+86-519-519-85557386 marketing1@neostarunited.com China 13172 58
Wuhan ChemNorm Biotech Co.,Ltd.
+86-27-8439 4403 18971486879 sales@chemnorm.com CHINA 2935 58

View Lastest Price from ASC-J9 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
ASC-J9;(1E,4Z,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one pictures 2019-09-03 ASC-J9;(1E,4Z,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one
52328-98-0
US $1.00-2.00 / KG 1KG 95.0-99.8% 1KG;5KG 10KG; 100KG Career Henan Chemical Co
1,4,6-Heptatrien-3-one, 1,7-bis(3,4-diMethoxyphenyl)-5-hydroxy-,(1E,4Z,6E)- (1E,4Z,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one Dimethylcurcumin GO-Y 025 (1E,4Z,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one (ASC-J9) Dimethylcurcumin, ≥95% Dimethylcurcumin【(1E,4Z,6E)-1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one】 Indiscriminate 4',4"-O,O-DIMETHYLCURCUMIN-D6 1,7-Bis(3,4-dimethoxyphenyl)-5-hydroxy-1,4,6-heptatrien-3-one 52328-98-0